Prevalence and Risk Factors for Sulfadoxine Antibody Among Patients Undergoing Treatment for Malaria in Benin City, Nigeria
Objectives: Because of lack of data on the prevalence of sulfadoxine antibody, this study was conducted to determine the prevalence of sulfadoxine antibodies and its possible risk factors. Methods: Blood specimens were collected from 500 patients undergoing treatment for malaria at Central Hospital,...
Main Authors: | Kingsley Ikuoyogie, Helen Oroboghae Ogefere, Richard Omoregie |
---|---|
Format: | Article |
Language: | English |
Published: |
Oman Medical Specialty Board
2017-05-01
|
Series: | Oman Medical Journal |
Subjects: | |
Online Access: | http://omjournal.org/articleDetails.aspx?coType=1&aId=1964 |
Similar Items
-
Meta-analysis of intermittent treatment with sulfadoxine-pyrimethamine in pregnancy in malaria endemic areas
by: Mkopi, Abdallah Bakari
Published: (2018) -
Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
by: A Sowunmi, et al.
Published: (2005-07-01) -
Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01) -
Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
by: Mary C. Oguike, et al.
Published: (2016-12-01) -
Uptake of intermittent preventive treatment for malaria in pregnancy among women in selected communities of Ebonyi State, Nigeria
by: Christian Obasi Akpa, et al.
Published: (2019-12-01)